Pentwater Capital Management’s Moderna MRNA Stock Holding History

Pentwater Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,000	Closed	-$393K	–	347
2021 Q1	$393K	Sell	3,000 -500	-14%	-$72.5K	﹤0.01%	302
2020 Q4	$366K	Sell	3,500 -15,000	-81%	-$1.52M	﹤0.01%	210
2020 Q3	$1.31M	Sell	18,500 -10,000	-35%	-$697K	0.02%	144
2020 Q2	$1.83M	Buy	28,500 +10,000	+54%	+$548K	0.03%	80
2020 Q1	$554K	Sell	18,500 -16,500	-47%	-$380K	0.01%	102
2019 Q4	$685K	Buy	35,000 +18,000	+106%	+$319K	0.01%	117
2019 Q3	$271K	Buy	+17,000	New	+$251K	﹤0.01%	144
2019 Q2	–	Sell	-10,000	Closed	-$204K	–	201
2019 Q1	$204K	Sell	10,000 -10,000	-50%	-$186K	﹤0.01%	133
2018 Q4	$305K	Buy	+20,000	New	+$329K	﹤0.01%	132

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Pentwater Capital Management's MRNA Position: Q2 2021 in Review

Pentwater Capital Management sold out of Moderna (MRNA) in Q2 2021, closing a stake of 3,000 shares — an estimated $393K sold.

Pentwater Capital Management first reported a position in MRNA in Q4 2018 and held it in 9 quarters. The position peaked at $1.83M in Q2 2020. 903 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.

Pentwater Capital Management reported no remaining Moderna position as of Q2 2021 after selling out during the quarter.
Pentwater Capital Management sold 3,000 Moderna shares in Q2 2021, an estimated $393K.
Pentwater Capital Management first reported a position in Moderna in Q4 2018 and held it in 9 quarters.
Pentwater Capital Management's Moderna position peaked at $1.83M in Q2 2020.
903 funds tracked by Wall St. Rank held Moderna as of Q2 2021.

Based on Pentwater Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.